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Background/aim: To determine the seroprevalence and evaluate clinical findings and laboratory results of patients prediagnosed with
Crimean-Congo hemorrhagic fever (CCHF) in Gümüşhane.
Materials and methods: Included in the cross-sectional study were 362 patients (162 female, 200 male) between 0 and 94 years of age,
who were followed up after receiving a preliminary diagnosis of CCHF between January 2011 and December 2019. Anamnesis, age, sex,
clinical findings, laboratory results, epidemiological and clinical evaluations, severity criteria, risk factor reviews, and a comparison of
the suspected negative cases with positive cases were analyzed retrospectively. Patients included in the study were evaluated as RNApositive by polymerase chain reaction (PCR) or IgM-positive by ELISA.
Results: Of the 362 patients admitted to health institutions with a preliminary diagnosis of CCHF, 242 were diagnosed as CCHFpositive (66.9%). Moreover, 196 of those CCHF-positive patients (81%) were admitted to health institutions during the summer
months. Statistical analyses revealed a significant relationship between the incidence of CCHF and patients who had been in contact
with animals, lived in rural areas, and had engaged in farming and animal husbandry. In addition, fever, headache, diffuse bodily pain,
nausea and vomiting, diarrhea, fever of 38 °C or higher, tachycardia, elevated ALT/AST, creatine kinase (CK), and lactate dehydrogenase
(LDH) levels, leukopenia, and thrombocytopenia were detected in the CCHF-positive patients. Significant relations were found between
this disease and these symptoms. However, there was no significant relationship between the statistical evaluation of the disease and
bloody diarrhea, bodily bruises, rash, unconsciousness, gingival bleeding, hypotension, epistaxis, petechiae, splenomegaly, ecchymosis,
hematuria, maculopapular rash, gastrointestinal system complaints, anemia, or elevation of the international normalized ratio and
activated partial thromboplastin time duration, separately.
Conclusion: Of the 362 patients, 66.9% (242) of those who received a preliminary diagnosis of CCHF were indeed CCHF-positive in
Gümüşhane. It was concluded that CCHF remains an important endemic disease in Gümüşhane. In addition, elevated ALT/AST, CK,
and LDH levels, leukopenia, and thrombocytopenia in patients presenting with headache, fever, fever of 38 °C or higher, generalized
body pain, nausea/vomiting, diarrhea, and tachycardia will play a pivotal role in the preliminary diagnosis of CCHF.
Key words: Crimean-Congo hemorrhagic fever, seroprevalence, clinical and laboratory findings

1. Introduction
Crimean-Congo hemorrhagic fever (CCHF) is a severe
and fatal disease that is transmitted by ticks and often
presents with bleeding symptoms in humans. The
causative agent is the CCHF virus, an RNA virus of the
Nairovirus lineage belonging to the family Bünyaviridae. It
was first described in the Crimea in 1944, when it affected
more than 200 people [1]. CCHF has been reported in
more than 30 countries in Eastern Europe, Africa, the
Balkans, Russia, Central Asian Republic, and the Middle
East. The spread of the virus over a wide geographic area

would result in a severe disease leading to high mortality
in humans. The absence of a specific effective treatment
and vaccine against the virus, in addition to its potential
to be used as a bioterror agent or biological weapon, have
made it an important human pathogen and a major public
health problem worldwide [2]. In Turkey, CCHF is mainly
seen in Erzurum, Erzincan, Gümüşhane, Bayburt, Tokat,
Yozgat, Sivas, Amasya, Çorum, Çankırı, Bolu, Kastamonu,
and Karabuk [3].
Climatic and environmental changes, increased
population of ticks, movement of livestock, and transport

* Correspondence: abdurrahman2400@gmail.com

This work is licensed under a Creative Commons Attribution 4.0 International License.

1825

GÜRBÜZ et al. / Turk J Med Sci
of virus-infected ticks through migratory birds all play
a role in the incidence of the disease. Transmission to
humans occurs via tick bites, or contact with the tissues
or blood of infected animals during the viremic period,
and the blood, secretions, and mucosal or disrupted skin
surfaces of infected patients with acute CCHF. Tick species
of Hyalomma marginatum, Amblyomma variegatum,
Haemaphysalis punctata, Hyalomma anatolicum,
Hyalomma truncatum, Rhipicephalus bursa have been
reported to play a role in the transmission of the virus.
However, field studies conducted in Turkey since 2005
have shown that the main tick species responsible for
CCHF epidemics was Hyalomma marginatum. The CCHF
virus has the most common geographic distribution
among tick-borne viruses [1,4–6].
There are 4 different stages in CCHF infection, which
include incubation, and the prehemorrhagic, hemorrhagic,
and convalescent periods. The incubation period of the
disease varies between 3 and 14 days, depending on the
route of transmission of the virus, the viral load, and the
immune status of the host. After the incubation period, the
prehemorrhagic stage begins with complaints like acute
fever (39–41 °C), diffuse muscle pain, severe headaches,
chills, trembling, nausea and vomiting, diarrhea, redness of
the face and conjunctiva, photophobia, and maculopapular
rash. Subsequent subcutaneous hemorrhage in the
form of petechiae, purpura, and ecchymosis, and
hemorrhagic symptoms, such as gum, nose, vagina,
gastrointestinal tract, urinary system, lung, and brain
hemorrhage, are seen in later stages of the disease. In
addition, lymphocyte, monocyte, and neutrophil counts
in these patients have been reported as significantly lower
than in CCHF-negative patients [7]. This reduction in
defense cells could have resulted from the induction of
hemophagocytosis. In a previous study, the presence of
effective hemophagocytosis was detected in half of the
patients [8]. Liver and spleen enlargement can be seen in
approximately one-third of patients. In cases with severe
disease during the concession period, unconsciousness,
agitation, hepatorenal insufficiency, respiratory failure,
disseminated intravascular coagulopathy, shock, and coma
may develop and death may occur.
The aim of this study was to determine the
seroprevalence of CCHF patients who applied to health
institutions in Gümüşhane province and evaluate the
relationship between CCHF and residing regions, seasons,
occupations, contact with animals, some clinical findings,
and laboratory results.
2. Materials and methods
A total of 362 patients, comprising 162 females and 200
males, between 0 and 94 years of age, who were followed
up with a preliminary diagnosis of CCHF between January
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2011 and December 2019 were included in this crosssectional study. The study received approval of the local
ethics committee. CCHF notification form records were
analyzed from beginning to end. Anamnesis, age, sex,
clinical findings, and laboratory results of the patients were
obtained from the information system of the Gümüşhane
Provincial Health Directorate. Epidemiological and
clinical evaluations, severity criteria, risk factor reviews,
and a comparison of suspected negative cases with positive
cases were analyzed retrospectively.
The patients included in the study were evaluated by
PCR method; RNA positivity or ELISA method; IgM
positivity. In the laboratory tests, alanine aminotransferase
(ALT) at 0–55 U/L, aspartate aminotransferase (AST) at
5–34 U/L, thrombocyte count at 3.5–11 10³/mm³, creatine
kinase (CK) at 30–200 U/L, platelet count at 142,000%–
424,000%, lactate dehydrogenase (LDH) at 0–247 mg/dL,
international normalized ratio (INR) of 0.8–1.24, activated
partial thromboplastin time (APTT) of 22–40 s, and
anemia at 11.7–18.8 g/dL were accepted as normal.
2.1. Statistical analyses
In the statistical evaluation, the incidence of the disease
was expressed as numbers and percentages according to
the relevant categorical variables. The relationship between
categorical variables was calculated using the Chi-square
(χ²) test. The Z-ratio test was used to determine the average
of the sample mean. Statistical significance level was taken
as 5% in calculations and MINITAB (Ver:14, Minitab Inc.,
State College, PA, USA) statistics package program was
used for calculations.
3. Results
Of the 362 patients included in this study, 55.3% were male
(n = 200) and 44.7% were female (n = 162). The mean age
was 46.2 years. The youngest of the patients admitted to
health institutions and followed up with the suspicion of
CCHF was just 10 days old, while the oldest was 94 years
old.
In 325 of the patients (93.9%) with a history of tick
bites, the tick was removed by the person themselves or
their relatives, while only 21 patients opted for removal by
health personnel (6.1%).
In total, 242 of the patients (66.9%) admitted to health
institutions with a preliminary diagnosis of CCHF were
diagnosed as CCHF-positive. Moreover, 196 of those 242
patients (81%) were admitted to the health institutions
during the summer months, and 8 of the 362 patients
(2.2%) admitted to health institutions with the suspicion
of CCHF died as a result.
When the relationship between the incidence of CCHF
and sex was examined, no significant relation was found in
the statistical evaluation (p > 0.05) (Table 1).
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Table 1. Distribution of the CCHF incidence by sex, animal
contact, place of residence and occupation.
CCHF

Sex

Contact
animals

Negative
N, %

Female

110 (67.9)

52 (32.1)

162

Male

132 (66)

68 (34)

200

Total

242 (66.9)

120 (33.1) 362

Positive

185 (78.7)

50 (21.3)

235

70 (55.1)

127

Negative 57 (44.9)

Total
Rural
zone
Place of
Town
residence center
Total

Job

Total
P-value
(100%)

Positive
N, %

242 (66.9)

120 (33.1) 362

206 (75.7)

66 (24.3)

272

36 (40)

54 (60)

90

242 (66.9)

120 (33.1) 362

Farming/
animal
149 (61.6)
husbandry

47 (39.2)

196

Other

58 (48.3)

138

8 (6.7)

14

7 (5.8)

13

Health
1 (0.4)
personnel

0 (0)

1

Total
(100%)

120

362

80 (33.1)

Student 6 (2.5)
Children
(0–5
6 (2.5)
years)

242

>0.05

<0.05

<0.05

When the relationship between the incidence of CCHF
and contact with animals was investigated, a statistically
significant relation was found (P < 0.05) (Table 1).
When the relationship between the incidence of CCHF
and place of residence was examined, it was observed that
more people living in rural areas had the disease than
people living in cities. A statistically significant relationship
was found between the incidence of CCHF and people
living in rural areas (p < 0.05), (Table 1).
When the distribution of the incidence of CCHF
according to occupations was examined, it was found that
people engaged in farming and animal husbandry had a
much higher rate of CCHF than those in other occupations
(Table 1).
Fever, headache, generalized body pain, nausea
and vomiting, diarrhea, fever of 38 °C or higher and
tachycardia were observed in CCHF-positive individuals.
There was a significant relation between the disease and
these symptoms (p < 0.05) (Table 2). Elevated ALT/AST,
CK, and LDH levels, leukopenia, and thrombocytopenia
were observed in CCHF-positive individuals. There

was a significant relation between the disease and these
laboratory findings (p < 0.05) (Table 2). However, there
was no significant relationship between the disease and
bloody diarrhea, bodily bruises, rash, unconsciousness,
gingival bleeding, hypotension, epistaxis, petechiae,
splenomegaly, ecchymosis, hematuria, maculopapular
rash, gastrointestinal system (GIS) complaints, anemia,
elevation of INR, or APTT duration, separately as clinical
symptoms and laboratory findings, in the statistical
evaluation (p > 0.05), (Table 2, Table 3).
4. Discussion
CCHF is a lethal viral causative infection that has been
identified in Africa, Asia, Western Europe, and the Middle
East. CCHF was the first viral hemorrhagic fever detected
in Turkey thus far and the first symptomatic case was
reported in 2002 in the Kelkit Valley in Tokat. Following
that, reports were made regarding CCHF from Artvin,
Amasya, Bayburt, Erzincan, Erzurum, Çorum, Çankırı,
Kastamonu, Sivas, and Yozgat. In recent years, the disease
areas have widened and cases have been reported from
every region of Turkey. A significant increase in CCHF
cases has been observed in Turkey since 2002. Most cases
of CCHF were observed in the Tokat, Yozgat, Çorum, Sivas,
Kastamonu, Karabuk, Gümüşhane, Erzurum, Amasya,
Çankırı, Giresun, and Samsun provinces of Turkey [9].
The fact that deaths were caused by tick bites in the
written and visual literature has resulted in serious
concern, sensitivity, and awareness against ticks in
society. In parallel, the number of patients admitted to
the emergency department has increased over the years.
When the number of CCHF cases was examined, it is
observed that there were 150 in 2002–2003, 249 in 2004,
266 in 2005, 438 in 2006, 717 in 2007, and 1315 in 2008
[9]. According to data from the Ministry of Health, a total
of 9787 cases of CCHF were reported in Turkey between
2002 and 2015 [10].
In the present study, of the 362 patients who were
followed up after receiving a preliminary diagnosis of
CCHF, 242 were diagnosed as CCHF-positive (66.9%).
The fact that CCHF was first reported in the Black Sea
region of Turkey, and that the positivity rate was high
in this study, led to the conclusion that CCHF is still an
important endemic disease in Gümüşhane [9].
Although the fight against ticks is very important in
the protection against CCHF, it is very difficult to achieve.
Ticks can suck blood by attacking humans and animals
in all biological stages except in the egg stage. Feeding
is essential in order to continue their development and
maintain generation. The basis of protection from ticks
is to avoid known tick habitats and the application of
pesticides to these areas [11].
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Table 2. Relationship between the incidence of CCHF and some clinical symptoms.
CCHF
Clinical signs and symptoms

Fever
Headache
Diffuse body pain
Nausea/vomiting
Diarrhea
Bloody diarrhea
Bodily bruises
Eruption
Fever of 38 °C or above
Consciousness disorder
Bleeding gums
Hypotension
Tachycardia
Epistaxis
Petechiae
Splenomegaly
Ecchymosis
Hematuria
Maculopapular skin
lesions
Presence of GIS complaint

1828

Positive
N, %

Negative
N, %

Total
(100%)

Positive

194 (72.9)

72 (27.1)

266

Negative

48 (50)

48 (50)

96

Positive

197 (75.2)

65 (24.8)

262

Negative

45 (45)

55 (55)

100

Positive

217 (76.1)

68 (23.9)

285

Negative

25 (32.5)

52 (67.5)

77

Positive

141 (73.1)

52 (26.9)

193

Negative

101 (59.8)

68 (40.2)

169

Positive

60 (78.9)

16 (21.1)

76

Negative

182 (63.6)

104 (36.4)

286

Positive

7 (77.8)

2 (22.2)

9

Negative

235 (66.6)

118 (33.4)

353

Positive

8 (72.7)

3 (27.3)

11

Negative

234 (66.7)

117 (33.3)

351

Positive

18 (69.2)

8 (30.8)

26

Negative

224 (66.7)

112 (33.3)

336

Positive

142 (73.2)

52 (26.8)

194

Negative

100 (59.5)

68 (40.5)

168

Positive

9 (3.7)

232 (96.3)

241

Negative

4 (3.3)

117 (96.7)

121

Positive

6 (2.5)

236 (97.5)

242

Negative

0 (0)

120 (100)

120

Positive

31 (75.6)

10 (24.4)

41

Negative

211 (65.7)

110 (34.3)

321

Positive

27 (84.4))

5 (15.6)

32

Negative

215 (65.2)

115 (34.8)

330

Positive

9 (75)

3 (25)

12

Negative

233 (66.6)

117 (33.4)

350

Positive

11 (73.3)

4 (26.6)

15

Negative

231 (66.6)

116 (33.4)

347

Positive

2 (40)

3 (60)

5

Negative

240 (67.2)

117 (32.8)

357

Positive

11 (84.6)

2 (15.4)

13

Negative

231 (66.2)

118 (33.8)

349

Positive

12 (80)

3 (20)

15

Negative

230 (66.3)

117 (33.7)

347

Positive

18 (78.3)

5 (21.7)

23

Negative

224 (66.1)

115 (33.9)

339

Positive

6 (75)

2 (25)

8

Negative

236 (66.7)

118 (33.3)

354

P-value

<0.05
<0.05
<0.05
<0.05
<0.05
>0.05
>0.05
>0.05
<0.05
>0.05
>0.05
>0.05
<0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
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Table 3. Relationship between the incidence of CCHF and some laboratory findings.
CCHF

Laboratory findings

Total
(100%)

Positive
N, %

Negative
N, %

Positive

47 (59.5%)

32 (40.5)

79

Negative

195 (68.9%)

88 (31.1)

283

Positive

151 (78.6%)

41 (20.9)

192

Negative

91 (53.5%)

79 (46.5)

170

Positive

202 (81.5%)

46 (18.5)

248

Negative

40 (35.1%)

74 (64.9)

114

Positive

142 (76.8)

43 (23.2)

185

Negative

100 (56.5)

77 (43.5)

177

Positive

188 (77.7)

54 (22.3)

242

Negative

54 (45)

66 (55)

120

LDH
elevation

Positive

147 (77)

44 (23)

191

Negative

95 (55.6)

76 (44.4)

171

INR
elevation

Above 1.2

42 (65.6)

22 (34.4)

64

Below 1.2

200 (67.1)

98 (32.9)

298

Over 15 s

74 (72.5)

28 (27.5)

102

Anemia
AST-ALT
elevation
Leukopenia
CK
elevation
Thrombocytopenia

APTT
time

Agricultural and livestock workers (animal caretakers,
milkers, and shearing workers, shepherds, butchers,
slaughterhouse workers), veterinarians, those in contact
with sick animals, and health personnel working in
endemic areas (due to the possibility of contact with
acute patients), soldiers, campers/picnickers, and leather
factory workers are at high risk. According to the data
of the Ministry of Health, 67% of infected patients were
engaged in agriculture and/or animal husbandry [4].
In a study conducted using data obtained from patients
diagnosed with CCHF between 2006 and 2012 in Bolu,
Turkey, 48.6% of the patients were housewives, 27% were
livestock workers, 10.8% were farmers, 5.4% were health
workers, and 8.1% were in other occupational groups [12].
In a study conducted in eastern Turkey, it was determined
that 98.4% of CCHF-positive patients resided in rural
areas and 72.1% had a history of contact with ticks [13].
Likewise, in a study conducted in Georgia, it was found
that the disease was mostly found in farmers and people
who lived in rural areas [14]. In a study investigating the
molecular and clinical epidemiology of CCHF in Oman
[15], the main risks of infection for contracting CCHF
were animal contact (73%) and butchery (88%). When
the distribution of ticks according to occupations was
examined in the current study, it was found that 54.1%
of the 362 patients were engaged in farming and animal
husbandry, 38.1% were from other occupational groups,

P-value
>0.05
<0.05
<0.05
<0.05
<0.05
<0.05
>0.05
>0.05

3.9% were students, 3.6% were children, and 0.3% were
health personnel. CCHF positivity was highest among
61.6% of those engaged in farming and animal husbandry,
while it was 33% in other occupational groups, 2.5% in
students and children, and 0.4% in health personnel. In
addition, a statistically significant relationship was found
between the incidence of CCHF and patients with a
history of contact with animals and people living in rural
areas (Table 1). Therefore, it was determined that it is
very important to raise awareness about CCHF, especially
for people living in endemic and rural areas, involved in
livestock and farming, and in contact with animals.
In the present study, 93.9% of the 346 patients with a
history of tick attachment removed the tick themselves or
it was removed by their relatives, while the rate of removal
by health personnel was only 6.1%. If ticks are not properly
removed, they cause tissue damage. There is a risk that the
capitulum of the tick will rupture and remain in the skin. In
addition, incorrect removal of the tick could also increase
the probability of transmission of the disease, even if the
host has not been infected yet [16]. In cases of tick bites in
endemic areas, individuals should seek medical assistance
at a health facility without delay and awareness should
be raised about the removal of ticks in accordance with
correct methods.
To summarize some of the studies carried out in line
with the data obtained from clinical findings of CCHF, in a
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study investigating the relationship between headache and
severity of CCHF, it was found that headache was more
severe in positive patients than in the control group and had
similar characteristics to the pain experienced by migraine
patients [17]. In another study conducted in Kastamonu, it
was found that headache and nausea/ vomiting associated
with leukopenia should be taken into consideration in
patients presenting with suspicion of CCHF [18]. In a
study conducted in Amasya, headache, fever, general body
pain, nausea and vomiting, and fatigue were among the
clinical symptoms that should be considered in CCHF
[19]. In another study, high fever was shown to be an
important symptom in CCHF patients [14]. In the current
study, 75.2% of patients with headache, 72.9% of patients
with fever, 73.2% of patients with fever of 38 °C or higher,
76.1% of patients with diffuse body pain, 73.1% of patients
with nausea and vomiting, 78.9% of patients with diarrhea,
and 84.4% of patients with tachycardia were diagnosed
with CCHF. A statistically significant relation was found
between CCHF and clinical symptoms of headache, fever,
fever of 38 °C or higher, diffuse body pain, nausea and
vomiting, diarrhea, and tachycardia (p < 0.05) (Table
2). It was concluded that CCHF should be considered
in individuals living or traveling to endemic areas who
present at health institutions with the indicated clinical
symptoms.
A Pakistani case report on CCHF showed that 4 of 6
patients had GIS complaints without any signs of bleeding
before the disease was suspected [20]. In another study,
a statistically significant relationship was found between
CCHF and epistaxis [21]. In the current study, no significant
relationship was found between CCHF and epistaxis, GIS,
bloody diarrhea, bodily bruising, rash, unconsciousness,
gingival bleeding, hypotension, petechiae, splenomegaly,
ecchymosis, hematuria, maculopapular rash, anemia,
elevation of INR, or duration of APTT (p > 0.05). There
are 4 different stages of CCHF infection [7]. Most of the
patients admitted in this study with suspicion of CCHF
were thought to be in the first 2 stages of incubation and
prehemorrhagic period. Epistaxis and GIS complaints
occur later in the disease. Therefore, it was thought that
there was no significant relationship between CCHF and
these complaints.
To summarize some of the studies carried out in
line with the data obtained from laboratory findings
in CCHF, it was reported by Büyüktuna et al. that
routine monitoring of AST levels may help patients with
bleeding conditions and additionally reduce liver damage
[22]. In addition, it was concluded that ferritin levels
could be a potential biomarker that would be useful in
monitoring patients. As a result of a study conducted
using data obtained from patients diagnosed with CCHF
in a hospital in Kastamonu, 41% of 76 CCHF-suspected
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patients were diagnosed as CCHF-positive [9]. It was
concluded that CCHF should be considered in cases of
elevated thrombocytopenia, ALT/AST, and LDH levels.
In a study conducted in Amasya, Turkey, 281 patients
admitted to a hospital were diagnosed with CCHF and it
was concluded that leukopenia, thrombocytopenia, and
elevated ALT/AST, CK and LDH levels should be taken
into consideration in the diagnosis of the disease [19]. In
a study of 240 patients admitted to a hospital in Çorum,
Turkey, with suspected CCHF, patients were diagnosed as
CCHF-positive via the RT-PCR method with regards to
the laboratory findings, leukopenia, thrombocytopenia,
and AST and potassium levels, which were statistically
significant between the patients and positive diagnoses
[21]. In a study conducted in Georgia, the laboratory
findings of CCHF-positive patients revealed that the most
prominent symptoms were intoxication and hemorrhagic
symptoms, thrombocytopenia, and high creatine and
aminotransferase levels [14]. In the current study, 78.6%
of patients with elevated ALT/AST levels, 81.5% of patients
with leukopenia, 76.8% of patients with elevated CK
levels, 77.7% of patients with thrombocytopenia, 77.7% of
patients with thrombocytopenia, and 77% of patients with
elevated LDH levels were diagnosed as CCHF-positive. A
statistically significant relation was found between CCHF
and the laboratory findings; elevated ALT/AST, CK, and
LDH levels, leukopenia, and thrombocytopenia (p < 0.001)
(Table 3). No statistically significant relationship existed
between CCHF and anemia, elevated INR or duration of
APTT (p > 0.05). Therefore, CCHF should be kept in mind
when diagnosing people living in or visiting endemic
areas, especially in patients with elevated ALT/AST, CK,
and LDH levels, leukopenia, and thrombocytopenia.
In a study investigating the relationship between
CCHF and climate characteristics, it was found that
there was a significant relationship between moisture and
precipitation data and the number of patients admitted
to hospitals with CCHF complaints [23]. Therefore, it is
important to consider climatic characteristics in regions
where CCHF has been diagnosed. In the current study, 81%
of patients who were CCHF-positive presented at health
institutions during the summer months. This is significant
because CCHF is a disease transmitted by ticks, which
become specifically more active as the weather warms up;
thus; the risk of contact with people increases. In addition,
people are also more likely to frequent places where ticks
are active during the summer months, enhancing their
risk of infection.
As a result, CCHF has been reported from almost every
region of Turkey, with varying frequency. In the summer
months, when CCHF incidence increases, the history
of animal contact and tick bites should be questioned
and examination specifically for ticks/tick bites should
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be performed. The public should be made aware of the
importance of removal of ticks by expert health personnel.
Raising awareness about CCHF should be performed
via visual and media announcements, and especially to
those working in farming and animal husbandry, and
living in rural areas where CCHF is endemic. Patients
admitted to health institutions with complaints including
headache, fever, fever of 38 °C or higher, diffuse bodily
pain, nausea and vomiting, diarrhea, or tachycardia, with
laboratory findings such as elevated ALT/AST, CK, and
LDH levels, leukopenia, and thrombocytopenia, should be
carefully examined for CCHF, as are the key markers in
its preliminary diagnosis. In addition, it will be of great

importance to take timely precautions for protection
against ticks, especially during the summer months when
ticks are more active.
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